Therefore, blocking of STAT3 signaling by AG490, a JAK2 inhibitor, or the knockdown of IL-6 using siRNA could re-sensitized drug-resistant osteosarcoma cells to doxorubicin and cisplatin [74,132]. The gene discussed is STAT3; the disease is osteosarcoma.